BioSpace News Archive

MJH Associates Inc., a full-service health care communications company has acquired Medical Networking, Inc., a privately held company that owns Medstro and MedTech Boston.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), named the Neuromuscular Disorders Program at Children’s Hospital of Wisconsin to be the 21st clinic to be named a Certified Duchenne Care Center, a designation created in 2014 as part of the organization’s Certified Duchenne Care Center Program.

Tonic Health announced today that Shriners Hospitals for Children is expanding the implementation of its mobile patient survey platform across the organization’s entire national footprint of non-profit hospitals, clinics and outreach facilities in order to achieve Shriners’ goal of building and utilizing the largest database of pediatric patient reported outcome measures (PROMs) in the United States.

Technavio analysts forecast the global aquaponics market to grow at a CAGR of over 11% during the forecast period, according to their latest market research report.

Headquarters to many of the nation’s renowned health organizations, the bioscience industry and leading health IT companies, Atlanta is also home to the burgeoning concierge medicine movement.

Medical device startup, HeartHero has signed an agreement to license VivaQuant MDSP cardiac arrhythmia detection technology for its portable AED.

INNIO today announces that Advent International has completed the acquisition of GE’s Distributed Power business and is now a stand-alone energy company rebranded as INNIO.

Qosina is pleased to introduce five new bonded, off-the-shelf extension lines (part #s 33066-33070).

Divurgent today announced that the firm brought on Robert Leahey as part of their growing team of principals. In his role as principal, Robert will lead the expansion and innovation of Divurgent’s current solutions to include broader scope and client audiences across Divurgent’s delivery capabilities.

Charles River Associates today announced that the Company will present several posters at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2018 annual meeting taking place November 10-14, 2018 at the International Convention Centre in Barcelona, Spain.